{"id":33402,"date":"2025-09-15T13:01:09","date_gmt":"2025-09-15T13:01:09","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/korea-reinforces-biopharma-leadership-at-global-bio-conference-2025\/"},"modified":"2025-09-15T13:01:09","modified_gmt":"2025-09-15T13:01:09","slug":"korea-reinforces-biopharma-leadership-at-global-bio-conference-2025-2","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=33402","title":{"rendered":"Korea reinforces biopharma leadership at Global Bio Conference 2025"},"content":{"rendered":"<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SEOUL, South Korea<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Sept. 15, 2025<\/span><\/span> \/PRNewswire\/ &#8212; This is an article published in The Korea Herald:<\/p>\n<p>The Ministry of Food and Drug Safety on Thursday announced its successful hosting of the Global Bio Conference 2025 in <span class=\"xn-location\">Seoul<\/span> last week, under the theme &#8220;Bio, Navigating Infinite Possibilities.&#8221;<\/p>\n<p>The three-day event \u2014 held <span class=\"xn-chron\">Sept. 3-5<\/span> at the Grand InterContinental Seoul Parnas in southern <span class=\"xn-location\">Seoul<\/span> \u2014 brought together about 4,530 participants, including 94 experts from 21 countries, alongside representatives from academia, the pharmaceutical industry and regulatory authorities.<\/p>\n<p>The conference, marking its eleventh year, provided a platform to share the latest research, development and regulatory trends, and discuss strategies for future growth.<\/p>\n<p>It highlighted the latest developments in advanced biopharmaceuticals, covering quality management trends and global regulatory harmonization, and reviewed cases of emerging vaccine platforms such as self-amplifying RNA.<\/p>\n<p>Emerging challenges amid rapid technological advances, such as artificial intelligence and regulatory considerations to expand patient access, were also addressed.<\/p>\n<p>Global regulatory cooperation was another focal point. Officials from <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">Australia<\/span>, <span class=\"xn-location\">Ecuador<\/span>, <span class=\"xn-location\">Japan<\/span>, <span class=\"xn-location\">Thailand<\/span> and other countries joined the global regulators workshop to share practices on approval and review systems, policy updates and collaborative initiatives.<\/p>\n<p>The head of <span class=\"xn-location\">Ecuador&#8217;s<\/span> regulatory authority attended to request effective implementation of the reference system to accelerate the approval of Korean medicines, while a dedicated session with pharmaceutical firms explored strategies for entering Latin American markets.<\/p>\n<p>The Food and Drug Safety Ministry commented that it will continue to support the conference as a leading platform for global regulatory cooperation, while promoting the competitiveness of Korean biopharmaceuticals and supporting them in achieving early entry into overseas markets.<\/p>\n<p>A total of 11 one-on-one meetings between Korean companies and overseas regulators were held during the conference, aiming to support their global market expansion and address industry challenges.<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SEOUL, South Korea<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Sept. 15, 2025<\/span><\/span> \/PRNewswire\/ &#8212; This is an article published in The Korea Herald:<\/p>\n<p>The Ministry of Food and Drug Safety on Thursday announced its successful hosting of the Global Bio Conference 2025 in <span class=\"xn-location\">Seoul<\/span> last week, under the theme &#8220;Bio, Navigating Infinite Possibilities.&#8221;<\/p>\n<p>The three-day event \u2014 held <span class=\"xn-chron\">Sept. 3-5<\/span> at the Grand InterContinental Seoul Parnas in southern <span class=\"xn-location\">Seoul<\/span> \u2014 brought together about 4,530 participants, including 94 experts from 21 countries, alongside representatives from academia, the pharmaceutical industry and regulatory authorities.<\/p>\n<p>The conference, marking its eleventh year, provided a platform to share the latest research, development and regulatory trends, and discuss strategies for future growth.<\/p>\n<p>It highlighted the latest developments in advanced biopharmaceuticals, covering quality management trends and global regulatory harmonization, and reviewed cases of emerging vaccine platforms such as self-amplifying RNA.<\/p>\n<p>Emerging challenges amid rapid technological advances, such as artificial intelligence and regulatory considerations to expand patient access, were also addressed.<\/p>\n<p>Global regulatory cooperation was another focal point. Officials from <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">Australia<\/span>, <span class=\"xn-location\">Ecuador<\/span>, <span class=\"xn-location\">Japan<\/span>, <span class=\"xn-location\">Thailand<\/span> and other countries joined the global regulators workshop to share practices on approval and review systems, policy updates and collaborative initiatives.<\/p>\n<p>The head of <span class=\"xn-location\">Ecuador&#8217;s<\/span> regulatory authority attended to request effective implementation of the reference system to accelerate the approval of Korean medicines, while a dedicated session with pharmaceutical firms explored strategies for entering Latin American markets.<\/p>\n<p>The Food and Drug Safety Ministry commented that it will continue to support the conference as a leading platform for global regulatory cooperation, while promoting the competitiveness of Korean biopharmaceuticals and supporting them in achieving early entry into overseas markets.<\/p>\n<p>A total of 11 one-on-one meetings between Korean companies and overseas regulators were held during the conference, aiming to support their global market expansion and address industry challenges.<\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-33402","post","type-post","status-publish","format-standard","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/33402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33402"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/33402\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}